Vera Therapeutics, Inc. (VERA)
31.79
+0.04
(+0.13%)
USD |
NASDAQ |
Jun 09, 16:00
31.79
0.00 (0.00%)
After-Hours: 19:46
Vera Therapeutics SG&A Expense (Quarterly) : 39.12M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 28.24M |
| Revolution Medicines, Inc. | 101.25M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Vaxcyte, Inc. | 33.07M |
| CG Oncology, Inc. | 20.78M |